Christian Sebastian Fuentes

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Instituto de Diagnóstico e Investigaciones Metabólicas(Current)

Centro de Pesquisas Oncológicas

Washington University in St. Louis

Townsville Hospital

Dr. H. Bliss Murphy Cancer Centre

Christian Sebastian Fuentes is an author at Instituto de Diagnóstico e Investigaciones Metabólicas specializing in oncology, pembrolizumab therapy, and medicine.

Publications per year

2022–2025

Publications

Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial

Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes et al. · Journal of Clinical Oncology · 2024 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14

651O Pembrolizumab (pembro) + carboplatin (carbo) + paclitaxel (pacli) as first-line (1L) therapy in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Phase VI KEYNOTE-B10 study

M.R. Dzienis, J.E. Cundom, Christian Sebastian Fuentes et al. · Annals of Oncology · 2022 · 21 citations

Medicine, Oncology, Pharmacology +14

Vepdegestrant, a PROTAC estrogen receptor (ER) degrader, vs fulvestrant in ER-positive/human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer: Results of the global, randomized, phase 3 VERITAC-2 study.

Erika Hamilton, Michelino De Laurentiis, Komal Jhaveri et al. · Journal of Clinical Oncology · 2025 · 13 citations

Medicine, Oncology, Pharmacology +15

1–3 of 3